Robert E. Gagnon, Director of Harvard Bioscience HBIO, has filed 0 purchases and 23 sales on the open market. Over the past 12 months that comes to a net sale of $43.2K. The latest trade was on 06/09.

RG

RG

Robert E. Gagnon

Director

Company

Harvard Bioscience HBIO

First filing

23/03/20

Trades

37 trades

Buys / sales

0 / 23

12-month net buying

−$43.2K

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Opus GeneticsIRD	Open-market sale	04/23	04/27	7,842 sh	$5.18	$40,621.56	−1.3%
VerastemVSTM	Open-market sale10b5-1 plan	25/12/16	25/12/18	283 sh	$9.14	$2,586.62	−0.7%
VerastemVSTM	Open-market sale10b5-1 plan	25/09/16	25/09/18	281 sh	$9.99	$2,807.19	−0.7%
VerastemVSTM	Open-market sale	25/06/16	25/06/20	284 sh	$5.65	$1,604.6	−0.7%
VerastemVSTM	Open-market sale	25/03/17	25/03/19	284 sh	$6.95	$1,973.8	−0.8%
VerastemVSTM	Open-market sale	24/12/16–24/12/19	24/12/20	415 sh2 trades	$4.49avg.	$1,862	−1.2%
VerastemVSTM	Open-market sale	24/09/19	24/09/20	131 sh	$2.79	$365.49	−0.4%
VerastemVSTM	Open-market sale	24/09/16	24/09/18	287 sh	$2.80	$803.6	−0.8%
VerastemVSTM	Open-market sale	24/06/17–24/06/20	24/06/20	414 sh2 trades	$3.40avg.	$1,408.18	−1.2%
VerastemVSTM	Open-market sale	24/03/18–24/03/19	24/03/20	413 sh2 trades	$10.61avg.	$4,380.33	−1.5%
VerastemVSTM	Open-market sale10b5-1 plan	24/02/06	24/02/07	9,204 sh	$13.70	$126,094.8	−24.9%
VerastemVSTM	Open-market sale10b5-1 plan	24/01/12	24/01/17	9,204 sh	$10.95	$100,783.8	−19.9%
VerastemVSTM	Open-market sale	23/12/18–23/12/19	23/12/20	414 sh2 trades	$7.67avg.	$3,174.66	−0.9%
VerastemVSTM	Open-market sale	23/09/18–23/09/19	23/09/20	408 sh2 trades	$9.89avg.	$4,034.18	−0.9%
VerastemVSTM	Open-market sale	23/06/16–23/06/20	23/06/21	413 sh2 trades	$10.04avg.	$4,146.36	−0.9%
VerastemVSTM	Open-market sale	23/03/16–23/03/20	23/03/20	5,318 sh2 trades	$0.41avg.	$2,177.12	−0.9%